Open‐label study with the monoamine stabilizer (‐)‐OSU6162 in myalgic encephalomyelitis/chronic fatigue syndrome

Open‐label study with the monoamine stabilizer (‐)‐OSU6162 in myalgic encephalomyelitis/chronic fatigue syndrome

Abstract Objectives The purpose of the present study was to investigate the safety and tolerability of the monoaminergic stabilizer (‐)‐OSU6162 in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). In addition, a potential therapeutic effect of (‐)‐OSU6162 in ME/CFS was evalu...

Full description

Bibliographic Details
Main Authors: Sara Haghighi, Sara Forsmark, Olof Zachrisson, Arvid Carlsson, Marie K. L. Nilsson, Maria L. Carlsson, Robert C. Schuit, Carl‐Gerhard Gottfries
Format: Article
Language:English
Published: Wiley 2021-04-01
Series:Brain and Behavior
Subjects:
fatigue
ME/CFS
monoaminergic stabilizer
mood
Online Access:https://doi.org/10.1002/brb3.2040

Internet

https://doi.org/10.1002/brb3.2040

Similar Items